Dodd David A

Avg. Two Year Performance

(57%) Avg. Purchase Return
(25%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(22%)(30%)(57%)(54%)(57%)
Purchase Success Rate0 of 21 of 21 of 21 of 21 of 2
Average Sale Return(< 1%)(3%)(1%)7%0%
Sale Success Rate4 of 74 of 72 of 74 of 70 of 7

Geovax Labs, Inc.

Drugs » Biotechnology

President, CEO, Director:

Holdings: 26.66K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Medizone International Inc

Drugs » Drug Manufacturers - Major

Chief Executive Officer, Director:

Holdings: 2.0M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--